Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingmar Wolff

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Urology|August 14, 2017
Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter StudyIngmar Wolff, Anna Scavuzzo, Umberto Capitanio, et al.
Aktuelle Urologie|July 30, 2020
[Impact of the experience of urological senior physicians in Germany on professional and personal aspects]Ulrike H Necknig, Ingmar Wolff, Johannes Bründl, et al.
Urologia Internationalis|November 6, 2023
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE StudyDanijel Sikic, Christian Fiebig, Bernd Wullich, et al.
Cancers|February 24, 2024
Urine-Based Biomarker Test Uromonitor<sup>®</sup> in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of Diagnostic Test PerformanceAnton P Kravchuk, Ingmar Wolff, Christian Gilfrich, et al.
Plos One|September 22, 2017
Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic diseaseNina Wagener, Dominic Edelmann, Axel Benner, et al.
Diagnostics (Basel, Switzerland)|January 28, 2026
Diagnostic Performance and Clinical Utility of the Uromonitor<sup>®</sup> Molecular Urine Assay for Urothelial Carcinoma of the Bladder: A Systematic Review and Diagnostic Accuracy Meta-AnalysisJulio Ruben Rodas Garzaro, Anton Kravchuk, Maximilian Burger, et al.
Cancers|June 22, 2023
Patient's Desire and Real Availability Concerning Supportive Measures Accompanying Radical Prostatectomy: Differences between Certified Prostate Cancer Centers and Non-Certified Centers Based on Patient-Reported Outcomes within the Cross-Sectional Study ImproveIngmar Wolff, Martin Burchardt, Julia Peter, et al.
Aktuelle Urologie|November 21, 2019
[Knowledge of German-speaking urologists regarding the association between penile cancer and human papilloma virus: results of a survey of the European PROspective Penile Cancer Study (E-PROPS)]Steffen Lebentrau, Ingmar Wolff, Marie Christine Hempel, et al.
BJU International|June 26, 2024
Real-world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trialIngmar Wolff, Anton P Kravchuk, Ralph M Wirtz, et al.
Clinical Genitourinary Cancer|April 28, 2026
Digital PCR-Based Uromonitor for Molecular Detection of Bladder Cancer: A Multicenter Validation Study Comparing Quantitative PCR and Urine CytologyAnton Kravchuk, Julio Ruben Rodas Garzaro, Ralph Wirtz, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Urology|August 14, 2017
Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter StudyIngmar Wolff, Anna Scavuzzo, Umberto Capitanio, et al.
Aktuelle Urologie|July 30, 2020
[Impact of the experience of urological senior physicians in Germany on professional and personal aspects]Ulrike H Necknig, Ingmar Wolff, Johannes Bründl, et al.
Urologia Internationalis|November 6, 2023
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE StudyDanijel Sikic, Christian Fiebig, Bernd Wullich, et al.
Cancers|February 24, 2024
Urine-Based Biomarker Test Uromonitor<sup>®</sup> in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of Diagnostic Test PerformanceAnton P Kravchuk, Ingmar Wolff, Christian Gilfrich, et al.
Plos One|September 22, 2017
Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic diseaseNina Wagener, Dominic Edelmann, Axel Benner, et al.
Diagnostics (Basel, Switzerland)|January 28, 2026
Diagnostic Performance and Clinical Utility of the Uromonitor<sup>®</sup> Molecular Urine Assay for Urothelial Carcinoma of the Bladder: A Systematic Review and Diagnostic Accuracy Meta-AnalysisJulio Ruben Rodas Garzaro, Anton Kravchuk, Maximilian Burger, et al.
Cancers|June 22, 2023
Patient's Desire and Real Availability Concerning Supportive Measures Accompanying Radical Prostatectomy: Differences between Certified Prostate Cancer Centers and Non-Certified Centers Based on Patient-Reported Outcomes within the Cross-Sectional Study ImproveIngmar Wolff, Martin Burchardt, Julia Peter, et al.
Aktuelle Urologie|November 21, 2019
[Knowledge of German-speaking urologists regarding the association between penile cancer and human papilloma virus: results of a survey of the European PROspective Penile Cancer Study (E-PROPS)]Steffen Lebentrau, Ingmar Wolff, Marie Christine Hempel, et al.
BJU International|June 26, 2024
Real-world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trialIngmar Wolff, Anton P Kravchuk, Ralph M Wirtz, et al.
Clinical Genitourinary Cancer|April 28, 2026
Digital PCR-Based Uromonitor for Molecular Detection of Bladder Cancer: A Multicenter Validation Study Comparing Quantitative PCR and Urine CytologyAnton Kravchuk, Julio Ruben Rodas Garzaro, Ralph Wirtz, et al.
Pageof 5